Chamber of Commerce and Merck take legal action against U.S. drug price control measures.

Pharmaceutical giant Merck is suing the US government over the Inflation Reduction Act, which allows the government to dictate the price of medications for seniors and tax companies that refuse to comply. Merck claims the law violates its constitutional rights and sets a dangerous precedent for all businesses. The law also restricts free speech and requires companies to publicly call the government's price "fair." Merck's lawsuit raises constitutional issues, but price controls on pharmaceuticals could also be dangerous to patients' health. The American Society of Clinical Oncology warns that price controls could reduce access to new drugs and harm the pipeline for future cures.